Where is gsk based

We invest our charitable funds with nonprofit partners that are doing good for people in need in the communities where we live and work. The information you are about to be referred to may not comply with the local regulatory requirements.

Further information relevant to the local environment is available from the company or via the Product Information. From collaborating on clinical trials to providing high quality, balanced information about our medicines and vaccines, in all of our interactions we aim to be transparent about our work, operate with integrity, and always put the interests of patients first.

You can find more information on our disclosure of payments here. Despite having some of the best people and research facilities, experience has shown us that we can achieve even more through strong partnerships.

These can be with the NHS, other companies, non-profit organisations and the academic world. By working together we aim to improve the management of different conditions, introduce greater efficiency and to achieve our mission to help people to do more, feel better, live longer. The projects outlined below were undertaken over the last five years and, over this period, codes, regulations and laws governing the areas covered by the studies may have changed.

When reading the documents please be assured that all projects followed the particular standards in force at the time even though these may have subsequently changed. All of the featured case studies are intended to give an overview of the individual project including its background, the potential benefits for the patient, the NHS, GSK and any other stakeholders.

In all of our interactions we aim to be transparent about our work, operate with integrity, and always put the interests of patients first. We focus our financial resource on programmes that have the greatest potential to enable people to do more, feel better, live longer. Please return your completed request form to gsk. We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.

Turning that purpose into reality starts with our employee experience, because we know when we feel at our best, we perform at our best. More from Reuters. Sign up for our newsletter Subscribe for our daily curated newsletter to receive the latest exclusive Reuters coverage delivered to your inbox. Sign up. In , GlaxoSmithKline donated million albendazole tablets to treat lymphatic filariasis, or intestinal worms.

Shortly after, the sale of Avandia was restricted in the U. The products included Paxil, Avandia, and a baby ointment called Bactroban. The contaminated products were all manufactured in a plant in Puerto Rico. In , the plant closed after failed attempts to fix the plant after an FDA investigation. Paxil was marketed to teens and children despite FDA approval for adults only.

Wellbutrin was marketed to help patients with sexual dysfunction, weight loss, ADHD, and drug addiction despite FDA approval to treat only depression. GlaxoSmithKline was also charged with hiding knowledge of deadly side effects from diabetes drug Avandia. Studies show that Avandia can increase heart attack risk by up to 43 percent.